Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model

Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model

Introduction: Micro-computed tomography with nanoparticle contrast agents may be a suitable tool for monitoring the time course of the development and progression of tumors. Here, we suggest a practical and convenient experimental method for generating and longitudinally imaging murine liver cancer...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Sang Bu An, Kwangmo Yang MD, PhD, Chang Won Kim MD, PhD, Si Ho Choi PhD, Eunji Kim, Sung Dae Kim, Jae Soo Koh
Format: Artykuł
Język:English
Wydane: SAGE Publishing 2021-05-01
Seria:Technology in Cancer Research & Treatment
Dostęp online:https://doi.org/10.1177/15330338211016466

Internet

https://doi.org/10.1177/15330338211016466

Podobne zapisy